Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics - PubMed (original) (raw)
Review
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Eskild Petersen et al. Lancet Infect Dis. 2020 Sep.
Abstract
The objective of this Personal View is to compare transmissibility, hospitalisation, and mortality rates for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with those of other epidemic coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and pandemic influenza viruses. The basic reproductive rate (R0) for SARS-CoV-2 is estimated to be 2·5 (range 1·8-3·6) compared with 2·0-3·0 for SARS-CoV and the 1918 influenza pandemic, 0·9 for MERS-CoV, and 1·5 for the 2009 influenza pandemic. SARS-CoV-2 causes mild or asymptomatic disease in most cases; however, severe to critical illness occurs in a small proportion of infected individuals, with the highest rate seen in people older than 70 years. The measured case fatality rate varies between countries, probably because of differences in testing strategies. Population-based mortality estimates vary widely across Europe, ranging from zero to high. Numbers from the first affected region in Italy, Lombardy, show an all age mortality rate of 154 per 100 000 population. Differences are most likely due to varying demographic structures, among other factors. However, this new virus has a focal dissemination; therefore, some areas have a higher disease burden and are affected more than others for reasons that are still not understood. Nevertheless, early introduction of strict physical distancing and hygiene measures have proven effective in sharply reducing R0 and associated mortality and could in part explain the geographical differences.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Comment in
- Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
Standl F, Jöckel KH, Brune B, Schmidt B, Stang A. Standl F, et al. Lancet Infect Dis. 2021 Apr;21(4):e77. doi: 10.1016/S1473-3099(20)30648-4. Epub 2020 Aug 11. Lancet Infect Dis. 2021. PMID: 32795407 Free PMC article. No abstract available. - COVID-19 pandemic more than a century after the Spanish flu.
Javelle E, Raoult D. Javelle E, et al. Lancet Infect Dis. 2021 Apr;21(4):e78. doi: 10.1016/S1473-3099(20)30650-2. Epub 2020 Aug 11. Lancet Infect Dis. 2021. PMID: 32795410 Free PMC article. No abstract available.
Similar articles
- Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.
Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Soo RJJ, et al. Emerg Infect Dis. 2020 Aug;26(8):1933-1935. doi: 10.3201/eid2608.201229. Epub 2020 Apr 27. Emerg Infect Dis. 2020. PMID: 32339092 Free PMC article. - Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
Abdelrahman Z, Li M, Wang X. Abdelrahman Z, et al. Front Immunol. 2020 Sep 11;11:552909. doi: 10.3389/fimmu.2020.552909. eCollection 2020. Front Immunol. 2020. PMID: 33013925 Free PMC article. Review. - Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by the End of March in Northern Italy and First Week of April in Southern Italy.
Distante C, Piscitelli P, Miani A. Distante C, et al. Int J Environ Res Public Health. 2020 Apr 27;17(9):3025. doi: 10.3390/ijerph17093025. Int J Environ Res Public Health. 2020. PMID: 32349259 Free PMC article. - COVID-19: a conundrum to decipher.
Deshmukh V, Tripathi SC, Pandey A, Deshmukh V, Vykoukal J, Patil A, Sontakke B. Deshmukh V, et al. Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378. Eur Rev Med Pharmacol Sci. 2020. PMID: 32495923 - The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
Wu Z, Harrich D, Li Z, Hu D, Li D. Wu Z, et al. Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18. Rev Med Virol. 2021. PMID: 33350025 Free PMC article. Review.
Cited by
- Study of Otorhinolaryngological Manifestations in Symptomatic COVID-19-Positive Patients at Tertiary Health Care Hospital: A Cross-sectional Study.
Methwani DA, Deosthale N, Khadakkar S, Dhote K, Harkare V. Methwani DA, et al. Int Arch Otorhinolaryngol. 2024 Jul 5;28(4):e597-e602. doi: 10.1055/s-0044-1786831. eCollection 2024 Oct. Int Arch Otorhinolaryngol. 2024. PMID: 39464359 Free PMC article. - Impact of the COVID-19 pandemic on the quality of care for juvenile idiopathic arthritis patients: insights from Thailand.
Pinpattanapong R, Sukharomana M, Charuvanij S. Pinpattanapong R, et al. Orphanet J Rare Dis. 2024 Sep 2;19(1):320. doi: 10.1186/s13023-024-03330-7. Orphanet J Rare Dis. 2024. PMID: 39223582 Free PMC article. - Insight into genomic organization of pathogenic coronaviruses, SARS-CoV-2: Implication for emergence of new variants, laboratory diagnosis and treatment options.
Bedada FB, Gorfu G, Teng S, Neita ME. Bedada FB, et al. Front Mol Med. 2022 Oct 17;2:917201. doi: 10.3389/fmmed.2022.917201. eCollection 2022. Front Mol Med. 2022. PMID: 39157715 Free PMC article. Review. - Mortality, hospitalizations, and persistence of symptoms in the outpatient setting of the first COVID-19 wave in Brazil: results of SARS-Brazil cohort study.
Fonseca HAR, Pereira AJ, Nawa RK, Sant'Anna VAR, Almeida TF, Guimarães HP, Tognon AP, Marques LM, Silva LSCD, Bittencourt RS, Gomes CP, Martins PA, Oliveira AL, Milan EP, Dall'Orto FTC, Hoffman Filho CR, Almeida G, Hohmann FB, Moia DDF, Piano LPA, Machado FP, Soares RVP, Damiani LP, Assis SRL, Amaro Junior E, Rizzo LV, Berwanger O. Fonseca HAR, et al. Einstein (Sao Paulo). 2024 Aug 9;22:eAO0652. doi: 10.31744/einstein_journal/2024AO0652. eCollection 2024. Einstein (Sao Paulo). 2024. PMID: 39140573 Free PMC article. - Deviation from the recommended schedule: optimal dosing interval for a two-dose vaccination programme.
Wang Z, Röst G, Moghadas SM. Wang Z, et al. R Soc Open Sci. 2024 Jul 3;11(7):231971. doi: 10.1098/rsos.231971. eCollection 2024 Jul. R Soc Open Sci. 2024. PMID: 39076371 Free PMC article.
References
- WHO WHO characterizes COVID-19 as a pandemic. March 11, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-a...
- WHO Consensus document on the epidemiology of severe acute respiratory syndrome (SARS) 2003. https://www.who.int/csr/sars/WHOconsensus.pdf?ua=1
- WHO Coronavirus disease (COVID-19). Situation Report– 161. June 29, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous